file_name	file_id	cases.0.samples.0.portions.0.analytes.0.aliquots.0.submitter_id	cases.0.samples.0.portions.0.analytes.0.submitter_id	cases.0.samples.0.portions.0.slides.0.submitter_id	cases.0.samples.0.portions.0.submitter_id	cases.0.samples.0.submitter_id	cases.0.submitter_id	cases.0.case_id	cases.0.disease_type	cases.0.primary_site	cases.0.project.project_id	cases.0.samples.0.days_to_collection	cases.0.samples.0.initial_weight	cases.0.samples.0.is_ffpe	cases.0.samples.0.oct_embedded	cases.0.samples.0.pathology_report_uuid	cases.0.samples.0.portions.0.analytes.0.a260_a280_ratio	cases.0.samples.0.portions.0.analytes.0.aliquots.0.aliquot_id	cases.0.samples.0.portions.0.analytes.0.aliquots.0.concentration	cases.0.samples.0.portions.0.analytes.0.aliquots.0.source_center	cases.0.samples.0.portions.0.analytes.0.aliquots.0.state	cases.0.samples.0.portions.0.analytes.0.analyte_id	cases.0.samples.0.portions.0.analytes.0.analyte_type	cases.0.samples.0.portions.0.analytes.0.analyte_type_id	cases.0.samples.0.portions.0.analytes.0.concentration	cases.0.samples.0.portions.0.analytes.0.spectrophotometer_method	cases.0.samples.0.portions.0.analytes.0.state	cases.0.samples.0.portions.0.is_ffpe	cases.0.samples.0.portions.0.portion_id	cases.0.samples.0.portions.0.portion_number	cases.0.samples.0.portions.0.slides.0.percent_lymphocyte_infiltration	cases.0.samples.0.portions.0.slides.0.percent_monocyte_infiltration	cases.0.samples.0.portions.0.slides.0.percent_necrosis	cases.0.samples.0.portions.0.slides.0.percent_neutrophil_infiltration	cases.0.samples.0.portions.0.slides.0.percent_normal_cells	cases.0.samples.0.portions.0.slides.0.percent_stromal_cells	cases.0.samples.0.portions.0.slides.0.percent_tumor_cells	cases.0.samples.0.portions.0.slides.0.percent_tumor_nuclei	cases.0.samples.0.portions.0.slides.0.section_location	cases.0.samples.0.portions.0.slides.0.slide_id	cases.0.samples.0.portions.0.slides.0.state	cases.0.samples.0.portions.0.state	cases.0.samples.0.portions.0.weight	cases.0.samples.0.sample_id	cases.0.samples.0.sample_type	cases.0.samples.0.sample_type_id	cases.0.samples.0.state	cases.0.samples.0.tissue_type	cases.0.state	cases.0.demographic.submitter_id	cases.0.demographic.age_at_index	cases.0.demographic.days_to_birth	cases.0.demographic.days_to_death	cases.0.demographic.demographic_id	cases.0.demographic.ethnicity	cases.0.demographic.gender	cases.0.demographic.race	cases.0.demographic.state	cases.0.demographic.vital_status	cases.0.demographic.year_of_birth	cases.0.demographic.year_of_death	cases.0.exposures.0.submitter_id	cases.0.exposures.0.alcohol_history	cases.0.exposures.0.bmi	cases.0.exposures.0.exposure_id	cases.0.exposures.0.height	cases.0.exposures.0.state	cases.0.exposures.0.weight	cases.0.diagnoses.0.submitter_id	cases.0.diagnoses.0.age_at_diagnosis	cases.0.diagnoses.0.ajcc_pathologic_m	cases.0.diagnoses.0.ajcc_pathologic_n	cases.0.diagnoses.0.ajcc_pathologic_stage	cases.0.diagnoses.0.ajcc_pathologic_t	cases.0.diagnoses.0.ajcc_staging_system_edition	cases.0.diagnoses.0.classification_of_tumor	cases.0.diagnoses.0.days_to_diagnosis	cases.0.diagnoses.0.days_to_last_follow_up	cases.0.diagnoses.0.diagnosis_id	cases.0.diagnoses.0.icd_10_code	cases.0.diagnoses.0.last_known_disease_status	cases.0.diagnoses.0.morphology	cases.0.diagnoses.0.primary_diagnosis	cases.0.diagnoses.0.prior_malignancy	cases.0.diagnoses.0.prior_treatment	cases.0.diagnoses.0.progression_or_recurrence	cases.0.diagnoses.0.site_of_resection_or_biopsy	cases.0.diagnoses.0.state	cases.0.diagnoses.0.synchronous_malignancy	cases.0.diagnoses.0.tissue_or_organ_of_origin	cases.0.diagnoses.0.tumor_grade	cases.0.diagnoses.0.tumor_stage	cases.0.diagnoses.0.year_of_diagnosis	cases.0.diagnoses.0.treatments.0.submitter_id	cases.0.diagnoses.0.treatments.1.submitter_id	cases.0.diagnoses.0.treatments.0.state	cases.0.diagnoses.0.treatments.0.treatment_id	cases.0.diagnoses.0.treatments.0.treatment_or_therapy	cases.0.diagnoses.0.treatments.0.treatment_type	cases.0.diagnoses.0.treatments.1.state	cases.0.diagnoses.0.treatments.1.treatment_id	cases.0.diagnoses.0.treatments.1.treatment_or_therapy	cases.0.diagnoses.0.treatments.1.treatment_type	id
2ee0c211-17d4-4067-8520-0e1f7986793a.htseq.counts.gz	5121695c-6f2c-4fd5-b75e-25d75d1aa567	TCGA-W5-AA30-01A-31R-A41I-07	TCGA-W5-AA30-01A-31R	TCGA-W5-AA30-01A-03-TS3	TCGA-W5-AA30-01A-31	TCGA-W5-AA30-01A	TCGA-W5-AA30	b4f7f9e4-5fc5-4461-8e0b-0b6c384863c6	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1134	200.0	False	true	9C2BEED7-DB8C-4BFE-920A-DD716B884777	1.9	f53d3bb4-4d10-4321-b41b-87fed60e6fc1	0.17	23	released	3e4e0d80-8dfa-4493-bdf2-8e0d2aee2572	RNA	R	0.17	UV Spec	released	False	fbe422d3-3324-4ca7-b818-dd04caa60de4	31	3.0	1.0	0.0	3.0	0.0	25.0	75.0	75.0	TOP	43cee268-44b1-49c6-aa78-0efc959fee72	released	released	30.0	89e6b4b4-2151-4167-a762-3948a475f3f2	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA30_demographic	82	-30039		9a4d8165-63d6-584c-9014-a408c4a4a069	not hispanic or latino	male	white	released	Alive	1928		TCGA-W5-AA30_exposure	Not Reported	28.859212313263917	b572f09c-b80c-5b58-9765-acd94ef2fae9	188.0	released	102.0	TCGA-W5-AA30_diagnosis	30039	M0	N0	Stage I	T1	7th	not reported	0	1153	dadfc534-efc9-5e40-81dc-cba85b50a3f0	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2010	TCGA-W5-AA30_treatment_1	TCGA-W5-AA30_treatment	released	0275ee9e-da82-5b30-8791-6dc263cc7e2e	no	Pharmaceutical Therapy, NOS	released	5a58f928-d1aa-5f48-aa50-56b9214d6c69	no	Radiation Therapy, NOS	5121695c-6f2c-4fd5-b75e-25d75d1aa567
35c9fca2-c634-480b-962f-e6fc542d2a01.htseq.counts.gz	7a5b1cfb-e4d1-4989-bfc0-6eb2afb31e2e	TCGA-W5-AA39-01A-11R-A41I-07	TCGA-W5-AA39-01A-11R	TCGA-W5-AA39-01A-01-TS1	TCGA-W5-AA39-01A-11	TCGA-W5-AA39-01A	TCGA-W5-AA39	32e9558c-946b-4288-91e1-504e47c308ac	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1286	220.0	False	true	733CC9D1-7D35-4976-9CD9-B8B8542313E2	1.73	342a4721-d5b0-487f-a2a7-a8ef6b7a924c	0.15	23	released	9a69a5f4-c660-44eb-bfb3-57332db8351b	RNA	R	0.15	UV Spec	released	False	b4bd08ab-2523-470c-9268-6692128a6701	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	95.0	TOP	69ba9fa7-0e57-4862-8a11-62570df1a8c0	released	released	30.0	f2b5ab58-8c49-4e47-8b06-c4422d5c345a	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA39_demographic	81	-29594	170	15f9936d-b9f8-5201-a6ad-c54100739b1a	not hispanic or latino	male	white	released	Dead	1929	2010	TCGA-W5-AA39_exposure	Not Reported	25.826446280991732	9dd1863e-1bab-5f11-abc2-fbb046f207d9	176.0	released	80.0	TCGA-W5-AA39_diagnosis	29594	M0	N0	Stage II	T2	7th	not reported	0		0223d7fb-4b16-53e3-aa82-37a6618dba34	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage ii	2010	TCGA-W5-AA39_treatment	TCGA-W5-AA39_treatment_1	released	c63c29b9-70ad-552f-82af-b6467f17f3b0	no	Radiation Therapy, NOS	released	a330dff2-7e71-509f-a5d7-00862d232d39	no	Pharmaceutical Therapy, NOS	7a5b1cfb-e4d1-4989-bfc0-6eb2afb31e2e
662bbe73-fded-44c1-abf4-bbae3f65ae3b.htseq.counts.gz	efb2d3a5-b73d-4895-865c-4c27d4c142bc	TCGA-W5-AA2U-11A-11R-A41I-07	TCGA-W5-AA2U-11A-11R	TCGA-W5-AA2U-11A-01-TS1	TCGA-W5-AA2U-11A-11	TCGA-W5-AA2U-11A	TCGA-W5-AA2U	aaacf22c-2362-4613-b024-88fb7dd1cca1	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1430	90.0	False	true		1.9	a59098ee-abee-46cc-af4a-cca9d501daec	0.16	23	released	97775ec7-5746-4611-a584-3afa19670cea	RNA	R	0.16	UV Spec	released	False	3edd4f3d-5d3b-4712-a90e-fdfc6f1aa62f	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	316af912-a850-4280-be94-4d5ca1517468	released	released	30.0	97aad42e-953b-4cc1-9bbc-3c1f8af662bd	Solid Tissue Normal	11	released	Not Reported	released	TCGA-W5-AA2U_demographic	78	-28552	627	426cd7cf-377b-5709-920e-cf88e06c03c2	not hispanic or latino	female	white	released	Dead	1932	2011	TCGA-W5-AA2U_exposure	Not Reported	24.654832347140037	f687dce0-6d4f-58bb-87bb-6ba1ecd9b13b	156.0	released	60.0	TCGA-W5-AA2U_diagnosis	28552	M0	N0	Stage I	T1	7th	not reported	0		3d7ae2c5-855d-58c6-823f-89fad7bfd668	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2010	TCGA-W5-AA2U_treatment_1	TCGA-W5-AA2U_treatment	released	e17eb819-82d7-5b3e-abc8-50fd298031e9	no	Pharmaceutical Therapy, NOS	released	f8a98bcf-af7a-5e1e-a12c-87a8f20db8ab	no	Radiation Therapy, NOS	efb2d3a5-b73d-4895-865c-4c27d4c142bc
e57fc205-c603-4fda-9524-85257817f713.htseq.counts.gz	f5cf4d3b-50f0-4c39-a8c3-450436f5844a	TCGA-W5-AA2I-11A-11R-A41I-07	TCGA-W5-AA2I-11A-11R	TCGA-W5-AA2I-11A-01-TSA	TCGA-W5-AA2I-11A-11	TCGA-W5-AA2I-11A	TCGA-W5-AA2I	3c8ca064-a4a7-416f-a069-4324d4a72038	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	3131	150.0	False	true		1.82	a8aea83d-802a-48b3-aea2-65e78fefc9b0	0.16	23	released	d21454d1-a242-4bec-ba2f-4917be8c6a0d	RNA	R	0.16	UV Spec	released	False	e9bb5cbf-f89d-4e44-ba15-291cfa4920de	11	2.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	a5550410-60ae-4379-9d50-c7fc484ca9bc	released	released	30.0	cde3c5fe-efa1-40cb-896b-82534d30986e	Solid Tissue Normal	11	released	Not Reported	released	TCGA-W5-AA2I_demographic	66	-24388	1939	2c7d4763-c4ac-514b-b61c-e8d1c7c2defa	not hispanic or latino	male	white	released	Dead	1939	2010	TCGA-W5-AA2I_exposure	Not Reported	39.4520893826537	3f1fb58b-f8bb-5aac-8f51-e8e72ded3696	178.0	released	125.0	TCGA-W5-AA2I_diagnosis	24388	M0	N0	Stage I	T1	6th	not reported	0		b196499e-cc2c-5e46-a50a-bd2ec45ecb20	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2005	TCGA-W5-AA2I_treatment_1	TCGA-W5-AA2I_treatment	released	119b1c52-dbc9-52b1-a34e-38360d6cbf9d	no	Pharmaceutical Therapy, NOS	released	10202bfb-52b1-5598-aefb-d6271b3caf3e	no	Radiation Therapy, NOS	f5cf4d3b-50f0-4c39-a8c3-450436f5844a
725eaa94-5221-4c22-bced-0c36c10c2c3b.htseq.counts.gz	85bc7f81-51fb-4446-b12d-8741eef4acee	TCGA-3X-AAV9-01A-72R-A41I-07	TCGA-3X-AAV9-01A-72R	TCGA-3X-AAV9-01A-07-TS7	TCGA-3X-AAV9-01A-72	TCGA-3X-AAV9-01A	TCGA-3X-AAV9	41b97b11-acaa-4fbc-b3b0-0abc1bcac13b	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1113	740.0	False	true	3E7DD345-7A2C-4D7B-B5A2-2207949186CA	1.83	59012a78-0e8f-4b99-af97-0dbb1d3d0513	0.15	23	released	a413c220-9976-4c54-8e3d-918a7982e6cb	RNA	R	0.15	UV Spec	released	False	dad7dc19-66a2-4532-a4a0-7a4576bc0d13	72	9.0	2.0	0.0	5.0	0.0	40.0	60.0	60.0	TOP	38564686-5d08-4066-98ee-f1e5a4fb85f1	released	released	30.0	c9df109c-cc7a-41cf-a034-b217d7e7674f	Primary Tumor	01	released	Not Reported	released	TCGA-3X-AAV9_demographic	72	-26349	339	48b46b2a-9442-5bba-85ff-18659de21a83	not hispanic or latino	male	asian	released	Dead	1938	2010	TCGA-3X-AAV9_exposure	Not Reported	18.206645425580337	563f6645-a578-5ad0-b178-f30d39b97bf2	169.0	released	52.0	TCGA-3X-AAV9_diagnosis	26349	M0	N0	Stage I	T1	7th	not reported	0		0489d320-0876-5cc8-98e1-c8fec034508a	C22.1	not reported	8160/3	Cholangiocarcinoma	yes	No	not reported	Intrahepatic bile duct	released	Not Reported	Intrahepatic bile duct	not reported	stage i	2010	TCGA-3X-AAV9_treatment_1	TCGA-3X-AAV9_treatment	released	4cb968fb-53d8-5bac-83e4-c2c588b114ed	yes	Pharmaceutical Therapy, NOS	released	22e03b71-ad02-5d49-99ca-b99b825f1167	no	Radiation Therapy, NOS	85bc7f81-51fb-4446-b12d-8741eef4acee
49f80167-5bbc-4f3e-aaa0-285d029b1202.htseq.counts.gz	7845948f-701e-49c5-8b76-2f0e2f0d5a76	TCGA-4G-AAZT-01A-11R-A41I-07	TCGA-4G-AAZT-01A-11R	TCGA-4G-AAZT-01A-01-TS1	TCGA-4G-AAZT-01A-11	TCGA-4G-AAZT-01A	TCGA-4G-AAZT	b10c64c2-7fd2-4210-b975-034affb14b57	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	45	330.0	False	false	C75C91FD-D4DE-4A58-A4C7-8F020AAC59EB	1.78	355d81ff-9689-4301-bd41-3df7403b533c	0.16	23	released	f0b74219-8d43-42ab-b83d-06b071f18819	RNA	R	0.16	UV Spec	released	False	7e4dfc89-ccfc-4cd3-a7a5-a7d5a8eb0c84	11	3.0	1.0	0.0	4.0	0.0	30.0	70.0	70.0	TOP	0e610786-fba0-4bd8-a6f8-8b2707070992	released	released	30.0	c2eca425-1bdf-425a-95bb-1d7b861c6689	Primary Tumor	01	released	Not Reported	released	TCGA-4G-AAZT_demographic	62	-22777		f0bb0161-a0c0-5d1b-b18b-930781523195	not hispanic or latino	male	white	released	Alive	1951		TCGA-4G-AAZT_exposure	Not Reported	21.224489795918366	526e75ea-105e-58b5-893b-fc36bd0a6d42	175.0	released	65.0	TCGA-4G-AAZT_diagnosis	22777	M0	N0	Stage I	T1	7th	not reported	0	420	58ad9803-07f3-5945-8a47-202f8271917b	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2013	TCGA-4G-AAZT_treatment	TCGA-4G-AAZT_treatment_1	released	141a32bd-abb3-5cd5-81d8-ecc88e35c098	no	Radiation Therapy, NOS	released	9efebfae-d545-5da9-8ea2-f293808afeea	no	Pharmaceutical Therapy, NOS	7845948f-701e-49c5-8b76-2f0e2f0d5a76
fc06a930-e3a1-4775-a126-610a531c655b.htseq.counts.gz	afecdda2-735c-4304-a087-ef917ad9cd5a	TCGA-W5-AA2R-01A-11R-A41I-07	TCGA-W5-AA2R-01A-11R	TCGA-W5-AA2R-01A-01-TSA	TCGA-W5-AA2R-01A-11	TCGA-W5-AA2R-01A	TCGA-W5-AA2R	20bf79af-3b0f-477d-b619-5597d42f5d5e	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	2542		False	true	153949E2-169E-4138-8D39-9EC9C61C7F3C	1.86	d3b1d5c8-a823-4630-a160-599bc0d5fb9a	0.16	23	released	ddb1b89e-1ea4-4003-b733-f9b06929db44	RNA	R	0.16	UV Spec	released	False	629ca5b5-9200-4d1a-bcad-b2e20c438580	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	TOP	92296cac-c184-438f-8282-9dc3786c0412	released	released	30.0	7a195a13-d4bb-417f-ae78-30cbd8039aac	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2R_demographic	77	-28367		f1b3e939-c2b1-5652-bc5b-db298895f2be	not hispanic or latino	female	white	released	Alive	1929		TCGA-W5-AA2R_exposure	Not Reported	28.841531805800354	13ea5144-504f-509c-9261-bb836b5a1909	158.0	released	72.0	TCGA-W5-AA2R_diagnosis	28367	M0	N0	Stage I	T1	6th	not reported	0	1542	c8c0536f-72e9-582b-8239-cdc3341ebe39	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2006	TCGA-W5-AA2R_treatment_1	TCGA-W5-AA2R_treatment	released	aa309569-dad8-5ccd-bcb8-b2e7d4d8a801	no	Pharmaceutical Therapy, NOS	released	a60fda6e-0956-5838-a5d8-429ca3cef035	no	Radiation Therapy, NOS	afecdda2-735c-4304-a087-ef917ad9cd5a
36efaf00-cc8e-437b-893d-6dcec1328022.htseq.counts.gz	fd0ea67b-5b75-471f-be3c-a92142b91cf3	TCGA-W5-AA34-01A-11R-A41I-07	TCGA-W5-AA34-01A-11R	TCGA-W5-AA34-01A-01-TS1	TCGA-W5-AA34-01A-11	TCGA-W5-AA34-01A	TCGA-W5-AA34	adc9a685-5b4a-4c29-881a-da1895c47520	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	461	140.0	False	true	36EAF28B-5091-4C1A-8BA6-D18C0407FC47	1.8	84e6718b-08c9-475d-906d-045e8f5477a0	0.15	23	released	17e0f927-6c29-4419-afb1-0a6909400861	RNA	R	0.15	UV Spec	released	False	f0a97c83-e713-43f7-bf75-1af005205dd9	11	4.0	0.0	5.0	0.0	0.0	0.0	95.0	70.0	TOP	f296e1b4-ac9c-4145-b473-0ae2faf71b06	released	released	30.0	3e5bea84-fede-4764-8922-fb4296feb2fe	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA34_demographic	75	-27535	555	42a98d55-df9c-511a-9467-5da4039dda49	not hispanic or latino	female	white	released	Dead	1937		TCGA-W5-AA34_exposure	Not Reported	27.734375	1aec3b10-8e5e-5a7d-8c4a-0aefea9690ed	160.0	released	71.0	TCGA-W5-AA34_diagnosis	27535	M0	N0	Stage I	T1	7th	not reported	0	168	d5ff64fb-4fe3-5ae2-b674-3e3176c2c30f	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2012	TCGA-W5-AA34_treatment	TCGA-W5-AA34_treatment_1	released	a170e48a-8238-503b-b904-c9a3e42b9d02	no	Radiation Therapy, NOS	released	aca43ad4-50da-55d1-a62d-bb34a761b7b9	yes	Pharmaceutical Therapy, NOS	fd0ea67b-5b75-471f-be3c-a92142b91cf3
de26b3ba-4ca2-4c78-b603-4eb240315148.htseq.counts.gz	42994602-7f8d-4d05-a191-9bcec686aaf7	TCGA-W5-AA2G-01A-11R-A41I-07	TCGA-W5-AA2G-01A-11R	TCGA-W5-AA2G-01A-01-TSA	TCGA-W5-AA2G-01A-11	TCGA-W5-AA2G-01A	TCGA-W5-AA2G	22bf93b3-c8dc-4669-862f-3e4ae478849b	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	2087	250.0	False	true	1E7EDF0B-283F-44F9-A89A-83DB12A0D58A	1.88	0431cd43-2dd6-4319-8017-6ed8b8e77dc0	0.16	23	released	f1829729-9158-45b2-b255-928ceb8c24c9	RNA	R	0.16	UV Spec	released	False	a37b437a-ec64-4667-aa9b-1550fd4b34b3	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	TOP	218c4e4d-766e-4ca4-8e27-adfe132c3f1f	released	released	30.0	42a1aec6-f8eb-4397-a8e0-04c23b15b7ed	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2G_demographic	62	-22933		a640dd4a-3934-588a-9c29-80d0e1e1e4fb	not hispanic or latino	female	white	released	Alive	1946		TCGA-W5-AA2G_exposure	Not Reported	20.56880661366243	f50b3141-d776-5a25-8d5b-e59867f2e28d	159.0	released	52.0	TCGA-W5-AA2G_diagnosis	22933	M0	N0	Stage I	T1	7th	not reported	0	1976	ec7b76e7-2b56-59bf-b5d0-a7f01fc9c955	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2008	TCGA-W5-AA2G_treatment	TCGA-W5-AA2G_treatment_1	released	bac8e9e4-b3c9-5fd5-9085-45d711a21402	no	Radiation Therapy, NOS	released	9e53572d-b5be-5528-95da-c5552fb14dde	no	Pharmaceutical Therapy, NOS	42994602-7f8d-4d05-a191-9bcec686aaf7
c2765336-c804-4fd2-b45a-e75af2a91954.htseq.counts.gz	6e2031e9-df75-48df-b094-8dc6be89bf8b	TCGA-3X-AAVB-01A-31R-A41I-07	TCGA-3X-AAVB-01A-31R	TCGA-3X-AAVB-01A-03-TSC	TCGA-3X-AAVB-01A-31	TCGA-3X-AAVB-01A	TCGA-3X-AAVB	3824cd6d-c85c-4b21-819a-932d1afef976	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	386	420.0	False	true	BEA4C577-73ED-48F0-9417-AA8BD143B5C8	1.89	88336d42-a31c-448f-a077-2608786c80fe	0.18	23	released	5ba1d3a3-9799-40ba-b5d0-7be969a26f74	RNA	R	0.18	UV Spec	released	False	bbcb07a2-326f-4553-9d6b-9be1c6a74669	31	5.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	TOP	7c63e346-3b04-474a-aa94-e37b57d2263b	released	released	30.0	6bfa1691-ee61-4458-9ca2-94d349588ce4	Primary Tumor	01	released	Not Reported	released	TCGA-3X-AAVB_demographic	70	-25819		cc86552f-df54-5b25-bbe1-aa1acfb20d71	not hispanic or latino	female	white	released	Alive	1942		TCGA-3X-AAVB_exposure	Not Reported	26.297577854671278	b44edd2e-fa6d-5e18-8948-7dc0b6c09fe9	170.0	released	76.0	TCGA-3X-AAVB_diagnosis	25819	M1	N1	Stage IVB	T3	7th	not reported	0	402	807a2c37-df33-518c-abab-e33bf35f7457	C24.0	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage ivb	2012	TCGA-3X-AAVB_treatment	TCGA-3X-AAVB_treatment_1	released	964c483a-5b83-5a14-95f5-56d5c270c2fd	not reported	Radiation Therapy, NOS	released	583b3df1-82eb-524f-bdcb-b531438f06d1	not reported	Pharmaceutical Therapy, NOS	6e2031e9-df75-48df-b094-8dc6be89bf8b
d3b8d3bc-ac3b-434f-b40b-dcd8235fb87a.htseq.counts.gz	8e31c3bb-40c8-48e2-9de1-1ee1ee31aac8	TCGA-ZH-A8Y8-01A-51R-A41I-07	TCGA-ZH-A8Y8-01A-51R	TCGA-ZH-A8Y8-01A-05-TSE	TCGA-ZH-A8Y8-01A-51	TCGA-ZH-A8Y8-01A	TCGA-ZH-A8Y8	5cf3911a-f3ea-4c0e-851d-5bb57ca7190f	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	69	390.0	False	false	D35938C2-CFED-444E-8284-B1A4D5EAD0F3	1.84	6d6c5a87-0773-418f-ae97-52e1cec8b8b1	0.16	23	released	d987b9bc-0985-442d-bc31-60c61174d64a	RNA	R	0.16	UV Spec	released	False	d0258295-3282-4671-826a-0628c383a0dc	51	0.0	0.0	0.0	0.0	15.0	0.0	85.0	75.0	TOP	b924de00-d688-4982-ae32-20ba28deafb0	released	released	30.0	f641043f-e789-4205-b5f7-ece67af60025	Primary Tumor	01	released	Not Reported	released	TCGA-ZH-A8Y8_demographic	73	-26744		399b9b62-a89f-5726-83cb-1ec375518977	not hispanic or latino	male	white	released	Alive	1940		TCGA-ZH-A8Y8_exposure	Not Reported	29.263340201260114	bf0d2fb7-9ac2-5076-8e76-a6a86d33c84a	183.0	released	98.0	TCGA-ZH-A8Y8_diagnosis	26744	M0	N0	Stage I	T1	7th	not reported	0	602	26bbcb2d-5a8a-59a8-ba86-1f7b7ac57aab	C22.1	not reported	8160/3	Cholangiocarcinoma	yes	No	not reported	Intrahepatic bile duct	released	Not Reported	Intrahepatic bile duct	not reported	stage i	2013	TCGA-ZH-A8Y8_treatment_1	TCGA-ZH-A8Y8_treatment	released	06dfe6d7-8e30-5ecb-8b69-e8a1b13edda8	no	Pharmaceutical Therapy, NOS	released	f90b5675-478a-57ff-812a-f33dab28f707	no	Radiation Therapy, NOS	8e31c3bb-40c8-48e2-9de1-1ee1ee31aac8
468c5071-fbaf-4b2e-87f4-9c75ca0096be.htseq.counts.gz	b554b9e8-01c4-46ad-8909-5ada19fe5860	TCGA-W5-AA38-01A-11R-A41I-07	TCGA-W5-AA38-01A-11R	TCGA-W5-AA38-01A-01-TSA	TCGA-W5-AA38-01A-11	TCGA-W5-AA38-01A	TCGA-W5-AA38	48d17b17-348c-405a-ae92-f190372a3aac	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	875	150.0	False	true	626B6057-4EFB-4AC9-A761-6759D5EF9EC1	1.77	cf410999-4cac-4f7b-9062-bfd807c50355	0.16	23	released	e789bdd0-bd74-470f-a8d5-ef661e1ccf2a	RNA	R	0.16	UV Spec	released	False	70ff0945-d834-4d54-9d59-bb2e9eb1e589	11	0.0	0.0	0.0	0.0	0.0	25.0	75.0	80.0	TOP	87432545-5f32-411b-942a-e4adf8cc6ac3	released	released	30.0	3142e952-b78a-4e63-8537-de8771d78006	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA38_demographic	55	-20285		4e7ceeca-d467-51ce-b011-9c96ca72c300	not hispanic or latino	female	white	released	Alive	1956		TCGA-W5-AA38_exposure	Not Reported	25.864512471655328	ad83179a-0e6e-5fcb-b89c-af9e3809c442	168.0	released	73.0	TCGA-W5-AA38_diagnosis	20285	M0	N0	Stage I	T1	7th	not reported	0	1471	828666ca-185c-53e2-9b02-5bfd47d9c5ab	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2011	TCGA-W5-AA38_treatment_1	TCGA-W5-AA38_treatment	released	d899ab1b-75b2-529b-a62e-caa76d52110f	yes	Pharmaceutical Therapy, NOS	released	316df015-09b1-55e8-8c6d-8df8bda6eac3	no	Radiation Therapy, NOS	b554b9e8-01c4-46ad-8909-5ada19fe5860
04df2e2a-04c6-4a8d-9bf3-b7a7a075101e.htseq.counts.gz	8e06ea1c-dbca-4b01-8f00-e4259507a77a	TCGA-W5-AA2X-11A-11R-A41I-07	TCGA-W5-AA2X-11A-11R	TCGA-W5-AA2X-11A-01-TSA	TCGA-W5-AA2X-11A-11	TCGA-W5-AA2X-11A	TCGA-W5-AA2X	6e534dd3-81ac-4575-ab1e-02c21e10916d	Adenomas and Adenocarcinomas	Other and unspecified parts of biliary tract	TCGA-CHOL	1238	210.0	False	true		1.83	a6369fb0-1ca6-4215-9f2b-f4e8647e6f5a	0.17	23	released	a56d4206-8309-4a91-9466-0bceb77ec94c	RNA	R	0.17	UV Spec	released	False	48edd72c-dc6d-4305-b424-3339532314a0	11	4.0	1.0	0.0	0.0	94.0	6.0	0.0	0.0	TOP	e81ed3ce-0609-40ef-bab9-831bcc1880ce	released	released	30.0	2cf3891d-f4c1-478e-ad40-743cd4821066	Solid Tissue Normal	11	released	Not Reported	released	TCGA-W5-AA2X_demographic	67	-24797	271	16df8d49-14b4-57b9-bb70-f288356797ce	not hispanic or latino	male	white	released	Dead	1943	2010	TCGA-W5-AA2X_exposure	Not Reported	31.553659148768332	247910d0-5a86-552d-b096-22b59ba24032	167.0	released	88.0	TCGA-W5-AA2X_diagnosis	24797	M1	N1	Stage IVB	T2b	7th	not reported	0		1f12809f-8b6d-57f7-b45b-91392aa7b2cd	C24.0	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Extrahepatic bile duct	released	No	Extrahepatic bile duct	not reported	stage ivb	2010	TCGA-W5-AA2X_treatment_1	TCGA-W5-AA2X_treatment	released	c9c78afe-23a2-558e-a978-d97744daa21d	no	Pharmaceutical Therapy, NOS	released	ad615910-4be0-513b-997b-d367ef864fee	no	Radiation Therapy, NOS	8e06ea1c-dbca-4b01-8f00-e4259507a77a
46fd54e8-5ab7-43f1-bb88-01a163ff121f.htseq.counts.gz	4963b9af-7d7b-42cd-b057-2f894639e59f	TCGA-W5-AA2U-01A-11R-A41I-07	TCGA-W5-AA2U-01A-11R	TCGA-W5-AA2U-01A-01-TS1	TCGA-W5-AA2U-01A-11	TCGA-W5-AA2U-01A	TCGA-W5-AA2U	aaacf22c-2362-4613-b024-88fb7dd1cca1	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1430	120.0	False	true	205BDA9B-D391-4075-B1A6-32CBF06B06EF	1.89	41df36db-590f-4410-8d1d-b9afbbc9cecc	0.18	23	released	ecc1a8fb-626d-4cd5-88a0-6fb6f8083f8f	RNA	R	0.18	UV Spec	released	False	641c4e93-3d08-48fd-b171-c7d24993ed44	11	0.0	0.0	10.0	0.0	0.0	10.0	80.0	65.0	TOP	62a11ef4-41f3-4f13-a408-20d1bcb6ded8	released	released	30.0	fc94b207-8fbe-4267-9b40-b66ad66c565e	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2U_demographic	78	-28552	627	426cd7cf-377b-5709-920e-cf88e06c03c2	not hispanic or latino	female	white	released	Dead	1932	2011	TCGA-W5-AA2U_exposure	Not Reported	24.654832347140037	f687dce0-6d4f-58bb-87bb-6ba1ecd9b13b	156.0	released	60.0	TCGA-W5-AA2U_diagnosis	28552	M0	N0	Stage I	T1	7th	not reported	0		3d7ae2c5-855d-58c6-823f-89fad7bfd668	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2010	TCGA-W5-AA2U_treatment_1	TCGA-W5-AA2U_treatment	released	e17eb819-82d7-5b3e-abc8-50fd298031e9	no	Pharmaceutical Therapy, NOS	released	f8a98bcf-af7a-5e1e-a12c-87a8f20db8ab	no	Radiation Therapy, NOS	4963b9af-7d7b-42cd-b057-2f894639e59f
8b20cba8-9fd5-4d56-bd02-c6f4a62767e8.htseq.counts.gz	19e8fd21-f6c8-49b0-aa76-109eef46c2e9	TCGA-3X-AAVC-01A-21R-A41I-07	TCGA-3X-AAVC-01A-21R	TCGA-3X-AAVC-01A-02-TSB	TCGA-3X-AAVC-01A-21	TCGA-3X-AAVC-01A	TCGA-3X-AAVC	ff4131c9-537c-46cc-b495-9af60d431f5e	Adenomas and Adenocarcinomas	Gallbladder	TCGA-CHOL	428	230.0	False	true	88206A8B-257B-4C0F-B42C-905DEA9483FB	1.82	8c8d5e98-023b-4496-a237-2632c609f627	0.16	23	released	a24c32dc-44aa-437f-8c06-a18955f01bc5	RNA	R	0.16	UV Spec	released	False	041609c3-1cc7-4aa8-820b-99ef6e23f934	21	0.0	0.0	0.0	0.0	0.0	40.0	60.0	70.0	TOP	0fcfec9b-166d-4cd9-b151-463144ab039c	released	released	30.0	ad85b3c6-281a-48b6-a057-cbede73b75fb	Primary Tumor	01	released	Not Reported	released	TCGA-3X-AAVC_demographic	72	-26493		8beb89b7-7a32-5246-bb35-31e9fffeba2b	not hispanic or latino	female	white	released	Alive	1940		TCGA-3X-AAVC_exposure	Not Reported	41.13761322732486	8b07f44c-53ff-54ae-839b-25bb01b11bed	159.0	released	104.0	TCGA-3X-AAVC_diagnosis	26493	M0	N0	Stage I	T1	7th	not reported	0	709	d0f40ba7-dac9-56f2-b72b-3b6448343e2d	C24.0	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Gallbladder	released	No	Gallbladder	not reported	stage i	2012	TCGA-3X-AAVC_treatment	TCGA-3X-AAVC_treatment_1	released	e42fbe52-bad9-5808-af6e-c4a08f27f61f	no	Radiation Therapy, NOS	released	ec0abe20-e65c-5f5b-b967-93b3ebb57b52	no	Pharmaceutical Therapy, NOS	19e8fd21-f6c8-49b0-aa76-109eef46c2e9
6221d7ba-de98-418c-a341-2a6cbc3ccf23.htseq.counts.gz	3f34af32-53c9-4b97-8886-a3057991c466	TCGA-W5-AA2Q-11A-11R-A41I-07	TCGA-W5-AA2Q-11A-11R	TCGA-W5-AA2Q-11A-01-TSA	TCGA-W5-AA2Q-11A-11	TCGA-W5-AA2Q-11A	TCGA-W5-AA2Q	f47dbd99-920b-4b39-a1b0-6c152ad24884	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	2626	160.0	False	true		1.88	f86273ce-18c0-47f3-af69-2eac38089508	0.16	23	released	b906632d-7662-47d2-9669-fff9dcfec86e	RNA	R	0.16	UV Spec	released	False	e54c32af-0603-4262-9fdf-8b4a84eea9d2	11	4.0	1.0	0.0	2.0	80.0	20.0	0.0	0.0	TOP	32060cdf-78e2-4795-888b-8ff068b7c578	released	released	30.0	5a5aa04d-1111-4ef6-96ad-6eb2be91a383	Solid Tissue Normal	11	released	Not Reported	released	TCGA-W5-AA2Q_demographic	68	-25069		8ddb6cab-1df5-5bec-834e-ee2d50ae5db9	not hispanic or latino	male	white	released	Alive	1938		TCGA-W5-AA2Q_exposure	Not Reported	24.60973370064279	1904aee0-640c-5184-aedf-b9d7b78d6cf1	165.0	released	67.0	TCGA-W5-AA2Q_diagnosis	25069	M0	N0	Stage II	T2b	6th	not reported	0	50	6447140c-2fb7-5650-ba57-f25db7dd3979	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage ii	2006	TCGA-W5-AA2Q_treatment_1	TCGA-W5-AA2Q_treatment	released	412cf902-2997-5540-885a-baffb7fde316	no	Pharmaceutical Therapy, NOS	released	0ec46556-c7a9-5d4c-846f-113a6b5d52fb	no	Radiation Therapy, NOS	3f34af32-53c9-4b97-8886-a3057991c466
a15f6726-8746-4176-bc5a-1f6b4a8e0ee0.htseq.counts.gz	533b56af-6953-4e39-b23e-ddf9a06499a5	TCGA-W5-AA2T-01A-12R-A41I-07	TCGA-W5-AA2T-01A-12R	TCGA-W5-AA2T-01A-01-TS1	TCGA-W5-AA2T-01A-12	TCGA-W5-AA2T-01A	TCGA-W5-AA2T	8944fe2a-e32f-4898-a2c5-fb6751f602a4	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	2045	80.0	False	true	16492F27-A257-4DC8-84E8-E1F14B7DC3FD	1.83	d6580402-f691-479a-8b3c-582547b22b0c	0.15	23	released	f40c563f-2937-4dad-89df-98eac2aa0868	RNA	R	0.15	UV Spec	released	False	ab85a6bd-f199-49f9-8ef9-61111a7c6bed	12	0.0	0.0	0.0	0.0	35.0	0.0	65.0	60.0	TOP	f9d87772-3039-4df4-b7c7-66b9dca8fef9	released	released	30.0	239a9937-50ba-4c07-9046-224b48c2e7df	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2T_demographic	64	-23560	1220	9a11def8-f3ee-5bcb-a0aa-131941e03894	not hispanic or latino	female	white	released	Dead	1944	2011	TCGA-W5-AA2T_exposure	Not Reported	25.806451612903224	9cf6886d-1120-504e-9bf3-c6009942d84a	155.0	released	62.0	TCGA-W5-AA2T_diagnosis	23560	M0	N0	Stage II	T2	6th	not reported	0		63e8ac8c-b1cf-5552-bfc5-eb4e6159bd69	C22.1	not reported	8160/3	Cholangiocarcinoma	yes	No	not reported	Intrahepatic bile duct	released	Not Reported	Intrahepatic bile duct	not reported	stage ii	2008	TCGA-W5-AA2T_treatment_1	TCGA-W5-AA2T_treatment	released	e28b585f-951c-5bb6-a4c0-d48cc69a3a2c	yes	Pharmaceutical Therapy, NOS	released	dff225a8-41b9-5d9f-8cdb-7011e57d9ad7	yes	Radiation Therapy, NOS	533b56af-6953-4e39-b23e-ddf9a06499a5
855b771f-e894-43a8-ab38-99d0920783bd.htseq.counts.gz	4fc729ce-f4f2-492f-b305-10f51ca60972	TCGA-W5-AA30-11A-11R-A41I-07	TCGA-W5-AA30-11A-11R	TCGA-W5-AA30-11A-01-TSA	TCGA-W5-AA30-11A-11	TCGA-W5-AA30-11A	TCGA-W5-AA30	b4f7f9e4-5fc5-4461-8e0b-0b6c384863c6	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1134	190.0	False	true		1.91	e819d2ae-9cfb-4256-a15c-23fbb3683ee7	0.18	23	released	97c731b1-f8cf-48cd-a90f-c69ba1858ee9	RNA	R	0.18	UV Spec	released	False	29a342ad-f569-4f32-b1a8-579f82329f2e	11	2.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	21df9099-ab85-42f2-8027-4233d1308300	released	released	30.0	be72384d-c424-4553-9a80-0f37e4ced48e	Solid Tissue Normal	11	released	Not Reported	released	TCGA-W5-AA30_demographic	82	-30039		9a4d8165-63d6-584c-9014-a408c4a4a069	not hispanic or latino	male	white	released	Alive	1928		TCGA-W5-AA30_exposure	Not Reported	28.859212313263917	b572f09c-b80c-5b58-9765-acd94ef2fae9	188.0	released	102.0	TCGA-W5-AA30_diagnosis	30039	M0	N0	Stage I	T1	7th	not reported	0	1153	dadfc534-efc9-5e40-81dc-cba85b50a3f0	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2010	TCGA-W5-AA30_treatment_1	TCGA-W5-AA30_treatment	released	0275ee9e-da82-5b30-8791-6dc263cc7e2e	no	Pharmaceutical Therapy, NOS	released	5a58f928-d1aa-5f48-aa50-56b9214d6c69	no	Radiation Therapy, NOS	4fc729ce-f4f2-492f-b305-10f51ca60972
85bebda7-644b-4f9b-a928-b758f4fd9495.htseq.counts.gz	e7a3c801-4e2f-45fd-948b-cef353403afb	TCGA-W5-AA33-01A-11R-A41I-07	TCGA-W5-AA33-01A-11R	TCGA-W5-AA33-01A-01-TS1	TCGA-W5-AA33-01A-11	TCGA-W5-AA33-01A	TCGA-W5-AA33	5fb3affa-3661-48e8-a1cc-b533c862e8c5	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	959	170.0	False	true	FAB26B40-D86E-4937-9D4D-2473D2AA838F	1.86	e67b53ac-771f-4b92-aad8-da78c97f4bcb	0.17	23	released	3fe12e1e-a719-47ed-9554-c080dbcecd11	RNA	R	0.17	UV Spec	released	False	ce8e04d9-d448-4928-8c22-063de60fdfd5	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	TOP	a6ce040f-f2d8-4325-a05e-31a4f793843f	released	released	30.0	e235e45d-9cbe-4c11-8f49-38aa743763d2	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA33_demographic	60	-22090		05495fc7-b24c-5394-b160-e301c614ade4	not hispanic or latino	male	white	released	Alive	1951		TCGA-W5-AA33_exposure	Not Reported	34.72222222222222	0a616d72-5be4-5ec3-b224-e863ed7333ba	192.0	released	128.0	TCGA-W5-AA33_diagnosis	22090	M0	N0	Stage I	T1	7th	not reported	0	1449	158a0dd1-cd6e-563f-89b2-cf024d4d457d	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2011	TCGA-W5-AA33_treatment	TCGA-W5-AA33_treatment_1	released	1b1f2462-1b63-5ca0-8e6f-6533d9cf4974	no	Radiation Therapy, NOS	released	983834ab-a8ea-5661-9a97-2afd05627712	no	Pharmaceutical Therapy, NOS	e7a3c801-4e2f-45fd-948b-cef353403afb
faac986b-ed3c-4547-a4e0-387f2d4d63b0.htseq.counts.gz	b48c636d-ac52-40cd-8279-0215259f8406	TCGA-W5-AA2Q-01A-11R-A41I-07	TCGA-W5-AA2Q-01A-11R	TCGA-W5-AA2Q-01A-01-TSA	TCGA-W5-AA2Q-01A-11	TCGA-W5-AA2Q-01A	TCGA-W5-AA2Q	f47dbd99-920b-4b39-a1b0-6c152ad24884	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	2626	120.0	False	true	ED7C4C0A-BBCE-4136-B95F-4E49DB17EEE3	1.87	60f80712-30c2-4026-9853-9733f641c05f	0.15	23	released	2156d28b-a7f3-442f-8649-9e2d2b90498a	RNA	R	0.15	UV Spec	released	False	a9ab3ec4-d30a-4d5b-9105-bdda7bedef67	11	3.0	2.0	2.0	5.0	0.0	33.0	65.0	65.0	TOP	1602441f-2b92-467c-a64e-9c3b15453794	released	released	30.0	9652df1d-041f-4e14-9dfa-c3b89563debb	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2Q_demographic	68	-25069		8ddb6cab-1df5-5bec-834e-ee2d50ae5db9	not hispanic or latino	male	white	released	Alive	1938		TCGA-W5-AA2Q_exposure	Not Reported	24.60973370064279	1904aee0-640c-5184-aedf-b9d7b78d6cf1	165.0	released	67.0	TCGA-W5-AA2Q_diagnosis	25069	M0	N0	Stage II	T2b	6th	not reported	0	50	6447140c-2fb7-5650-ba57-f25db7dd3979	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage ii	2006	TCGA-W5-AA2Q_treatment_1	TCGA-W5-AA2Q_treatment	released	412cf902-2997-5540-885a-baffb7fde316	no	Pharmaceutical Therapy, NOS	released	0ec46556-c7a9-5d4c-846f-113a6b5d52fb	no	Radiation Therapy, NOS	b48c636d-ac52-40cd-8279-0215259f8406
be5bc6a0-9720-47ac-953e-fa8d0c32cd82.htseq.counts.gz	03aee74e-4e37-4a58-a720-c90e807d2f40	TCGA-W5-AA36-01A-11R-A41I-07	TCGA-W5-AA36-01A-11R	TCGA-W5-AA36-01A-01-TS1	TCGA-W5-AA36-01A-11	TCGA-W5-AA36-01A	TCGA-W5-AA36	f2d42e03-ca8d-4b57-ae39-0cc8f37b1b67	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	2007	100.0	False	true	6EC57D32-953A-4B46-AF10-A3AFCF636ED4	1.82	b8dabef1-a207-4c40-bf80-d61ad7dbf571	0.16	23	released	6e9ede4e-8f40-4587-aba6-c3fd9b6f0f6e	RNA	R	0.16	UV Spec	released	False	68121f68-4ee4-4acf-b9a4-625b4312fa67	11	0.0	0.0	0.0	0.0	0.0	30.0	70.0	80.0	TOP	6386ee7c-0c81-4b8f-b76d-5479a5bc7850	released	released	30.0	72b1d733-74a9-40da-a2e8-dff5d631c952	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA36_demographic	51	-18882	1402	e303b58e-3f34-519e-b4ee-b2e129c9b276	not hispanic or latino	female	white	released	Dead	1957	2011	TCGA-W5-AA36_exposure	Not Reported	24.97704315886134	12f18b88-e4d0-5b4e-971c-a75d6d6857be	165.0	released	68.0	TCGA-W5-AA36_diagnosis	18882	M1	N0	Stage IV	T3	6th	not reported	0		554e26ad-0f03-58ae-90e8-c3d3cfa32818	C22.1	not reported	8160/3	Cholangiocarcinoma	no	Yes	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage iv	2008	TCGA-W5-AA36_treatment_1	TCGA-W5-AA36_treatment	released	2097d2d3-f590-5aa6-93c8-9b291d05c215	yes	Pharmaceutical Therapy, NOS	released	7a2018ab-15b4-542e-87d4-cda79ae5f122	no	Radiation Therapy, NOS	03aee74e-4e37-4a58-a720-c90e807d2f40
5ded64c9-6e37-413e-9e1f-8aa27b29e783.htseq.counts.gz	3a39302b-b097-4371-a785-753c8dabb0a2	TCGA-W5-AA2W-01A-11R-A41I-07	TCGA-W5-AA2W-01A-11R	TCGA-W5-AA2W-01A-01-TS1	TCGA-W5-AA2W-01A-11	TCGA-W5-AA2W-01A	TCGA-W5-AA2W	1d136284-bdf5-498e-9506-4893801a337c	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1314	160.0	False	true	EB47A378-F3DA-4892-8126-99CEE6BFA8EE	1.71	6fcc3918-f4b0-42ab-b00c-027175606cbd	0.15	23	released	059bec9f-b51f-4752-822e-36a58131c7ff	RNA	R	0.15	UV Spec	released	False	c2effaf7-e88a-4ed0-98ad-6a5a7e8c78b4	11	5.0	1.0	1.0	1.0	0.0	54.0	45.0	90.0	TOP	2be0ba42-3d4d-485b-b3ea-b721f2018ff5	released	released	30.0	39d0161c-b2a2-4b75-9a16-e668403a759b	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2W_demographic	31	-11438	924	063ee8ad-4ce0-5942-aac4-b84f07dcf2eb	not hispanic or latino	female	white	released	Dead	1979	2012	TCGA-W5-AA2W_exposure	Not Reported	32.62935207429452	bae16a70-21b4-520c-82bf-b9bf37dbebfb	167.0	released	91.0	TCGA-W5-AA2W_diagnosis	11438	M0	N1	Stage IVA	T2a	7th	not reported	0		6cadcd0e-6dcf-556f-9248-6b5cbda9242f	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage iva	2010	TCGA-W5-AA2W_treatment	TCGA-W5-AA2W_treatment_1	released	6a8796d3-20a8-5d63-a106-aff6090dd666	no	Radiation Therapy, NOS	released	e70b1c30-0b69-5915-9efb-a11a4d9a0a45	yes	Pharmaceutical Therapy, NOS	3a39302b-b097-4371-a785-753c8dabb0a2
39fae157-a126-4635-a212-137065a398f9.htseq.counts.gz	0d2c466e-d8b8-4b8f-9909-0be2175fa6a0	TCGA-W5-AA2H-01A-31R-A41I-07	TCGA-W5-AA2H-01A-31R	TCGA-W5-AA2H-01A-03-TSC	TCGA-W5-AA2H-01A-31	TCGA-W5-AA2H-01A	TCGA-W5-AA2H	bc15cec4-1f82-47fe-ae69-3853194fab7e	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	474	180.0	False	true	46A92484-5ECB-4F04-9207-4188D015B9CD	1.93	b0ada585-0834-406b-b02c-b06c171882ff	0.18	23	released	419fe83d-0760-4408-ac76-e6b1de6f442d	RNA	R	0.18	UV Spec	released	False	2b288c32-7940-46d8-8c34-7899975db38e	31	5.0	1.0	0.0	3.0	0.0	30.0	70.0	70.0	TOP	0b5d214b-4e40-4ce3-afdf-d435754e6a34	released	released	30.0	41f648bb-b4cf-4e26-9342-a8f22529076d	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2H_demographic	70	-25775		81ac8ede-dff1-5e87-901e-276ed07dc6f3	not hispanic or latino	female	white	released	Alive	1942		TCGA-W5-AA2H_exposure	Not Reported	27.053802773967384	2ddfa96f-d8ef-5f64-aa01-b8c33a466641	162.0	released	71.0	TCGA-W5-AA2H_diagnosis	25775	M0	N0	Stage III	T3	7th	not reported	0	1077	069bb941-9010-52a2-9a8f-a910a6781a7f	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage iii	2012	TCGA-W5-AA2H_treatment_1	TCGA-W5-AA2H_treatment	released	b580946c-1857-5b83-9939-3a0cc57bb46a	yes	Pharmaceutical Therapy, NOS	released	70aa3e12-ab1a-5c26-92b9-d3f1db4cd9f9	no	Radiation Therapy, NOS	0d2c466e-d8b8-4b8f-9909-0be2175fa6a0
c696175b-9427-484b-8673-49a1c321f2fa.htseq.counts.gz	c32379fa-928f-4eec-b849-a5b715d1f9cb	TCGA-W6-AA0S-01A-11R-A41I-07	TCGA-W6-AA0S-01A-11R	TCGA-W6-AA0S-01A-01-TSA	TCGA-W6-AA0S-01A-11	TCGA-W6-AA0S-01A	TCGA-W6-AA0S	7047dc12-e2ed-40b7-86fd-c5c53a2766fd	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	235	210.0	False	true	2F3CE1B3-0DFD-4729-8A52-5E0BDE92BD12	1.86	f5475a42-4520-4124-9ace-8c0ed9eabefb	0.16	23	released	cf46a96c-558c-4c3b-b3cb-41faace91145	RNA	R	0.16	UV Spec	released	False	b851aa26-8f41-4e87-972f-5aa647899764	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	b5b0e8a3-cf2b-4c64-8bb9-2735170c19d1	released	released	30.0	bd707d1d-1407-4c21-be70-835bc88d70f6	Primary Tumor	01	released	Not Reported	released	TCGA-W6-AA0S_demographic	46	-16951		645795f3-e0a1-51fc-9aad-7e53f5808cd6	hispanic or latino	female	white	released	Alive	1967		TCGA-W6-AA0S_exposure	Not Reported	29.41743827160494	f16cd374-3c44-56b8-a2ce-64f65741ac63	144.0	released	61.0	TCGA-W6-AA0S_diagnosis	16951	MX	N0	Stage I	T1	7th	not reported	0	808	d779ffd9-f85f-5714-931e-dc2521470da3	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2013	TCGA-W6-AA0S_treatment	TCGA-W6-AA0S_treatment_1	released	e7e3cd1f-a16c-5329-b3fa-c3a160ae876c	no	Radiation Therapy, NOS	released	f237117a-eaf6-5a51-a4fb-f7bde7aa0418	yes	Pharmaceutical Therapy, NOS	c32379fa-928f-4eec-b849-a5b715d1f9cb
fbc4ffad-8a22-4531-8a3a-5761f40cfd82.htseq.counts.gz	13921de8-8580-4f26-88bb-49f71ea6e103	TCGA-WD-A7RX-01A-12R-A41I-07	TCGA-WD-A7RX-01A-12R	TCGA-WD-A7RX-01A-01-TSA	TCGA-WD-A7RX-01A-12	TCGA-WD-A7RX-01A	TCGA-WD-A7RX	4290b3b3-94f6-43e4-8309-430dd973ae2d	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	86	250.0	False	true	9D3F4AEF-2F52-4035-AFFC-A5AD2A31EE5D	1.8	015b2409-ca2e-4141-8266-fe619793761c	0.16	23	released	891ee5d4-7904-4da1-bffd-b12a786499e3	RNA	R	0.16	UV Spec	released	False	ad8b9aa6-0f39-4fb5-8330-802c09369362	12	15.0	1.0	1.0	1.0	4.0	39.0	56.0	80.0	TOP	45e6186f-0aec-4403-afe9-0b8630e8d225	released	released	30.0	b20c28ba-41c3-4638-a702-e4a89f58e563	Primary Tumor	01	released	Not Reported	released	TCGA-WD-A7RX_demographic	71	-26006	21	e1926bfb-45e1-572a-8a87-bf09004ea9ed	hispanic or latino	female	white	released	Dead	1942	2013	TCGA-WD-A7RX_exposure	Not Reported	23.60127724559211	0f694b4b-48dc-5770-9025-2c0df12977f4	147.0	released	51.0	TCGA-WD-A7RX_diagnosis	26006	MX	NX	Stage II	T2b	7th	not reported	0		2af48bf6-0035-52f4-b7ef-c5b881ae207d	C22.0	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Liver	released	No	Liver	not reported	stage ii	2013	TCGA-WD-A7RX_treatment_1	TCGA-WD-A7RX_treatment	released	53a3d806-2a2e-5ddc-85c4-dad2d42368a7	no	Pharmaceutical Therapy, NOS	released	e1de4ab0-6aa0-5d79-8f4f-f8d4b52e3de9	no	Radiation Therapy, NOS	13921de8-8580-4f26-88bb-49f71ea6e103
af387835-6795-467a-8103-e2083e7fb478.htseq.counts.gz	4e337123-ea4c-42e5-acb9-37fce1fa7fd5	TCGA-ZH-A8Y1-01A-11R-A41I-07	TCGA-ZH-A8Y1-01A-11R	TCGA-ZH-A8Y1-01A-01-TS1	TCGA-ZH-A8Y1-01A-11	TCGA-ZH-A8Y1-01A	TCGA-ZH-A8Y1	b16e9c3f-c7df-46c2-bee3-ecaebbab025f	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	426	550.0	False	false	B4025F42-46CB-4D4E-ABB4-DBF701615F14	1.94	11aba6d6-271d-4d59-a2be-8cbd88a48d40	0.18	23	released	06f38150-bf4e-4244-a2f0-a98be150883f	RNA	R	0.18	UV Spec	released	False	9eebe807-c041-4807-9362-1a9c09f62b35	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	TOP	e8568997-1f13-4a79-8dae-3f76055a4c08	released	released	30.0	0889104b-8289-44cc-b500-eaf303f859ac	Primary Tumor	01	released	Not Reported	released	TCGA-ZH-A8Y1_demographic	74	-27279	385	bba894f2-2136-5854-b765-9ef780cf4c5c	not hispanic or latino	female	white	released	Dead	1938	2013	TCGA-ZH-A8Y1_exposure	Not Reported	28.65013774104683	eac4db17-9fa8-5e52-a216-d9d077b73404	165.0	released	78.0	TCGA-ZH-A8Y1_diagnosis	27279	M0	N1	Stage IVA	T3	7th	not reported	0		358b4439-4382-5020-8dc6-7a2ac967586e	C22.1	not reported	8160/3	Cholangiocarcinoma	yes	No	not reported	Intrahepatic bile duct	released	Not Reported	Intrahepatic bile duct	not reported	stage iva	2012	TCGA-ZH-A8Y1_treatment	TCGA-ZH-A8Y1_treatment_1	released	7a3005c8-76a7-5b74-9cef-c0f5d61152e2	no	Radiation Therapy, NOS	released	70e4ae04-61bb-53f6-8344-3fc3dd9f1d73	yes	Pharmaceutical Therapy, NOS	4e337123-ea4c-42e5-acb9-37fce1fa7fd5
a8832eae-f36d-4ac5-b4c6-f8411a85d926.htseq.counts.gz	361cb97e-20ee-4a03-8c77-574fe10bf0d5	TCGA-ZH-A8Y4-01A-11R-A41I-07	TCGA-ZH-A8Y4-01A-11R	TCGA-ZH-A8Y4-01A-01-TS1	TCGA-ZH-A8Y4-01A-11	TCGA-ZH-A8Y4-01A	TCGA-ZH-A8Y4	95b69517-4971-450e-9ed0-43bc8b2c0534	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1315	80.0	False	false	8C44AB5C-5F49-4F12-9273-F8AEDD9F0316	1.94	012cd145-9f6c-4b79-b929-3f42f61e3dce	0.18	23	released	a3911bc2-4ea7-4e1b-8661-38fb192ce059	RNA	R	0.18	UV Spec	released	False	24ffa1b7-764b-454d-ad52-fd1f9aef097a	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	da0f8f25-4351-489b-b2a5-1c67542765af	released	released	30.0	69c14659-da45-46a7-bd76-7625ec37b2ce	Primary Tumor	01	released	Not Reported	released	TCGA-ZH-A8Y4_demographic	58	-21503	741	7e7edd8f-e3d2-5041-b7ea-586e0af84c3e	not hispanic or latino	male	white	released	Dead	1952	2012	TCGA-ZH-A8Y4_exposure	Not Reported	26.277285078682553	f1be0a15-af51-5e4d-9cb7-f4f6693dc6ae	183.0	released	88.0	TCGA-ZH-A8Y4_diagnosis	21503	M0	N0	Stage I	T1	7th	not reported	0		ed007a61-9736-549d-b186-f90b4088a9d5	C22.1	not reported	8160/3	Cholangiocarcinoma	yes	No	not reported	Intrahepatic bile duct	released	Not Reported	Intrahepatic bile duct	not reported	stage i	2010	TCGA-ZH-A8Y4_treatment_1	TCGA-ZH-A8Y4_treatment	released	94eb7e3c-8014-5a34-89ab-a03b3740ed0d	yes	Pharmaceutical Therapy, NOS	released	8eac65d4-4bc5-53d5-a501-716b0e7874bb	no	Radiation Therapy, NOS	361cb97e-20ee-4a03-8c77-574fe10bf0d5
3f3db8bd-f247-4e75-a137-7b84f5a7c6d2.htseq.counts.gz	50e857b6-77be-4dd6-ac94-4b2186129fcb	TCGA-ZH-A8Y2-01A-11R-A41I-07	TCGA-ZH-A8Y2-01A-11R	TCGA-ZH-A8Y2-01A-01-TS1	TCGA-ZH-A8Y2-01A-11	TCGA-ZH-A8Y2-01A	TCGA-ZH-A8Y2	47a9ef9b-04f0-4e8d-bfdb-0846ba30d08b	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	897	400.0	False	false	1D1D2814-ECEE-463D-9EF9-E27F9CDCFEB6	1.87	63a3bd41-6a68-4eb5-ad4f-0fd05be97ac1	0.15	23	released	de86ada5-d483-4fa0-8828-d421f375d31c	RNA	R	0.15	UV Spec	released	False	221331f7-fd8e-41b7-8a09-e507f484e887	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	TOP	9b298170-0b7a-4685-8ea3-3a2040ad9ffb	released	released	30.0	0dbd5678-f7c0-4611-98d0-126c414e29f6	Primary Tumor	01	released	Not Reported	released	TCGA-ZH-A8Y2_demographic	59	-21743	701	098a0045-4df9-5fba-837a-4e817f8631f7	not hispanic or latino	female	black or african american	released	Dead	1952	2012	TCGA-ZH-A8Y2_exposure	Not Reported	26.729927495071667	fe239501-f7fa-501c-aa21-aeb134b9a6d4	173.0	released	80.0	TCGA-ZH-A8Y2_diagnosis	21743	M0	NX	Stage I	T1	7th	not reported	0		bad5bd9d-d744-57e0-89ef-08e559cf4be3	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2011	TCGA-ZH-A8Y2_treatment_1	TCGA-ZH-A8Y2_treatment	released	4f56462e-9695-51e2-b263-c453de6e1ee4	yes	Pharmaceutical Therapy, NOS	released	f027d6fe-c9a7-5e74-b1f4-fc1b972ebb3e	yes	Radiation Therapy, NOS	50e857b6-77be-4dd6-ac94-4b2186129fcb
d5fb0f37-d8e0-4ec8-a3c5-dbc68e7b228f.htseq.counts.gz	f18234f6-9933-4aa7-8c17-f41f64569cf6	TCGA-YR-A95A-01A-12R-A41I-07	TCGA-YR-A95A-01A-12R	TCGA-YR-A95A-01A-01-TSA	TCGA-YR-A95A-01A-12	TCGA-YR-A95A-01A	TCGA-YR-A95A	779ce92d-1abd-44fc-9021-eda4d7f08fff	Adenomas and Adenocarcinomas	Other and unspecified parts of biliary tract	TCGA-CHOL	1589	130.0	False	false	AB615D8F-E4A3-48A9-86A3-C89861C89A5D	1.85	7bb15e31-2b7d-4926-b78a-0d2aa7bddd78	0.17	23	released	26bb681a-2ebc-487a-b1eb-ffea4cd24c9d	RNA	R	0.17	UV Spec	released	False	01ca76ed-ed8b-4c1a-a830-f72f30c7a0da	12	3.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	TOP	81fa50c6-e1d0-49e0-9e01-8389ef99ed76	released	released	10.0	5f8945f7-0023-45cc-ba81-bbdfdeede58c	Primary Tumor	01	released	Not Reported	released	TCGA-YR-A95A_demographic	52	-19292	26	2b1ecebd-47c6-55c5-bca3-45b325872343	not reported	male	white	released	Dead	1957	2009	TCGA-YR-A95A_exposure	Not Reported	24.577867151840145	37f43f2d-7db7-585f-aa28-d7823ccf5697	177.0	released	77.0	TCGA-YR-A95A_diagnosis	19292	M1	NX	Stage IV	T2	6th	not reported	0		c3d37a7b-54db-58b9-96b0-e975d7ea1bf9	C24.0	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Extrahepatic bile duct	released	No	Extrahepatic bile duct	not reported	stage iv	2009	TCGA-YR-A95A_treatment	TCGA-YR-A95A_treatment_1	released	9e7d8848-8050-567f-a435-4dacac02515e	no	Radiation Therapy, NOS	released	0a040e9c-50db-5678-a67d-26bc3651426b	no	Pharmaceutical Therapy, NOS	f18234f6-9933-4aa7-8c17-f41f64569cf6
99939497-52b7-4049-b221-12ff3332b634.htseq.counts.gz	494626b6-541d-417f-8ad0-1c4c44e25bef	TCGA-W5-AA2X-01A-11R-A41I-07	TCGA-W5-AA2X-01A-11R	TCGA-W5-AA2X-01A-01-TS1	TCGA-W5-AA2X-01A-11	TCGA-W5-AA2X-01A	TCGA-W5-AA2X	6e534dd3-81ac-4575-ab1e-02c21e10916d	Adenomas and Adenocarcinomas	Other and unspecified parts of biliary tract	TCGA-CHOL	1238	120.0	False	true	D2B18607-E16D-4570-9E96-5A7CBAFD79FC	1.86	1d507dd2-bb72-4305-a858-68fccae00d5e	0.17	23	released	4a711f1f-d504-45ea-a642-cb5aca91b20f	RNA	R	0.17	UV Spec	released	False	035952ab-6d4c-49d1-aa88-71a45d8e93e0	11	22.0	2.0	7.0	2.0	0.0	30.0	63.0	75.0	TOP	c8860cdc-4358-4ed6-839a-e551bd2cbc21	released	released	30.0	ca1d5a74-0687-4d12-abcc-7f21c2e9fbb6	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2X_demographic	67	-24797	271	16df8d49-14b4-57b9-bb70-f288356797ce	not hispanic or latino	male	white	released	Dead	1943	2010	TCGA-W5-AA2X_exposure	Not Reported	31.553659148768332	247910d0-5a86-552d-b096-22b59ba24032	167.0	released	88.0	TCGA-W5-AA2X_diagnosis	24797	M1	N1	Stage IVB	T2b	7th	not reported	0		1f12809f-8b6d-57f7-b45b-91392aa7b2cd	C24.0	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Extrahepatic bile duct	released	No	Extrahepatic bile duct	not reported	stage ivb	2010	TCGA-W5-AA2X_treatment_1	TCGA-W5-AA2X_treatment	released	c9c78afe-23a2-558e-a978-d97744daa21d	no	Pharmaceutical Therapy, NOS	released	ad615910-4be0-513b-997b-d367ef864fee	no	Radiation Therapy, NOS	494626b6-541d-417f-8ad0-1c4c44e25bef
fae43343-f746-4c1d-afb2-bb36967cee0f.htseq.counts.gz	7dd1c33e-35ef-406d-b516-5b3b2a486473	TCGA-W5-AA2Z-01A-11R-A41I-07	TCGA-W5-AA2Z-01A-11R	TCGA-W5-AA2Z-01A-01-TS1	TCGA-W5-AA2Z-01A-11	TCGA-W5-AA2Z-01A	TCGA-W5-AA2Z	20ec1cd9-7bdb-4eb9-9d20-65795580f1f5	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1178	120.0	False	true	22F994D3-20A5-46CD-958F-2AAAB3F2D2EC	1.78	df40ecd0-42b7-45be-9789-098cc3c85f34	0.16	23	released	80cbc4c5-a601-40f1-abc1-1425eb4d2d4a	RNA	R	0.16	UV Spec	released	False	8f37d4aa-87e7-4072-afb1-a52ba4aba39b	11	4.0	0.0	2.0	0.0	0.0	75.0	23.0	85.0	TOP	7e99b675-59b0-4a6d-aab0-40999e475316	released	released	30.0	17160d8c-f353-4c89-8a1a-c07fcdff8903	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2Z_demographic	29	-10659		394088da-f956-51ec-aeb8-638339775252	not hispanic or latino	female	white	released	Alive	1981		TCGA-W5-AA2Z_exposure	Not Reported	31.24523700655388	a1d70ca0-7bd2-585a-82cb-c440511c510c	162.0	released	82.0	TCGA-W5-AA2Z_diagnosis	10659	M0	N0	Stage II	T2	7th	not reported	0	1614	2767ec5a-d907-5e0b-85bf-13e621501e38	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage ii	2010	TCGA-W5-AA2Z_treatment	TCGA-W5-AA2Z_treatment_1	released	b43cf7ea-44dd-5c68-a9b3-c073ee279a23	no	Radiation Therapy, NOS	released	f0fd2eaf-3255-5416-944f-13b981c3b24f	yes	Pharmaceutical Therapy, NOS	7dd1c33e-35ef-406d-b516-5b3b2a486473
51724196-560a-47d6-adb4-5fb1ff622f21.htseq.counts.gz	b223180f-7a91-40dd-a3f1-ab423a820255	TCGA-W5-AA31-01A-11R-A41I-07	TCGA-W5-AA31-01A-11R	TCGA-W5-AA31-01A-01-TS1	TCGA-W5-AA31-01A-11	TCGA-W5-AA31-01A	TCGA-W5-AA31	2d6e20b2-82c7-4c12-92d0-93282b0a9031	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1079	180.0	False	true	A3B869CE-5B61-4F3E-930E-BC6CB37DD4F0	1.87	b4468779-3068-40d2-809c-7b513d0a752f	0.17	23	released	3d491167-15d5-4032-addf-44b912886177	RNA	R	0.17	UV Spec	released	False	7c09b5c1-d0a4-4813-af47-0761d8f5cd8c	11	10.0	0.0	5.0	0.0	0.0	0.0	95.0	60.0	TOP	e821d3a3-4e10-4336-9e5d-8d8fee937b9b	released	released	30.0	a7919c8d-b6f4-4404-b7c0-9ae43dc73ce7	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA31_demographic	71	-26139		60a87b01-2cf2-5cf6-a7ef-60a01a2c39cb	not hispanic or latino	male	white	released	Alive	1939		TCGA-W5-AA31_exposure	Not Reported	31.01370510396975	f97fbe9c-eba1-55e2-b444-fc4258e0885e	184.0	released	105.0	TCGA-W5-AA31_diagnosis	26139	M0	N0	Stage I	T1	7th	not reported	0	10	31529032-9657-5095-bc21-31b5c42020df	C22.1	not reported	8160/3	Cholangiocarcinoma	yes	No	not reported	Intrahepatic bile duct	released	Not Reported	Intrahepatic bile duct	not reported	stage i	2010	TCGA-W5-AA31_treatment	TCGA-W5-AA31_treatment_1	released	5dd979a9-f240-5875-94c6-87971863b9a5	no	Radiation Therapy, NOS	released	daf3ed7d-27b9-5da4-a860-b0b484c9d5e7	no	Pharmaceutical Therapy, NOS	b223180f-7a91-40dd-a3f1-ab423a820255
908d56cc-fda7-431b-963c-e8ca753f5561.htseq.counts.gz	e4e4df95-84e9-4811-9ff9-d3bf4f3be116	TCGA-W5-AA2R-11A-11R-A41I-07	TCGA-W5-AA2R-11A-11R	TCGA-W5-AA2R-11A-01-TS1	TCGA-W5-AA2R-11A-11	TCGA-W5-AA2R-11A	TCGA-W5-AA2R	20bf79af-3b0f-477d-b619-5597d42f5d5e	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	2542	220.0	False	true		1.87	2649a2ec-8bb0-486e-9eec-ac9c76021b60	0.17	23	released	886dd7d5-1b97-4c79-9362-19f78ca64d10	RNA	R	0.17	UV Spec	released	False	00154445-500c-4c2b-9de1-989507fd5061	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	32ee025c-ffad-4ed0-8d0e-8bcdc0fa44a9	released	released	30.0	3f83502d-82cd-4217-bbd8-938bdb31095d	Solid Tissue Normal	11	released	Not Reported	released	TCGA-W5-AA2R_demographic	77	-28367		f1b3e939-c2b1-5652-bc5b-db298895f2be	not hispanic or latino	female	white	released	Alive	1929		TCGA-W5-AA2R_exposure	Not Reported	28.841531805800354	13ea5144-504f-509c-9261-bb836b5a1909	158.0	released	72.0	TCGA-W5-AA2R_diagnosis	28367	M0	N0	Stage I	T1	6th	not reported	0	1542	c8c0536f-72e9-582b-8239-cdc3341ebe39	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2006	TCGA-W5-AA2R_treatment_1	TCGA-W5-AA2R_treatment	released	aa309569-dad8-5ccd-bcb8-b2e7d4d8a801	no	Pharmaceutical Therapy, NOS	released	a60fda6e-0956-5838-a5d8-429ca3cef035	no	Radiation Therapy, NOS	e4e4df95-84e9-4811-9ff9-d3bf4f3be116
6496c79a-4364-4adc-8c64-5c2fa17c0410.htseq.counts.gz	bd31db54-5544-41e6-abab-86f2e997cfe5	TCGA-W5-AA2O-01A-11R-A41I-07	TCGA-W5-AA2O-01A-11R	TCGA-W5-AA2O-01A-01-TSA	TCGA-W5-AA2O-01A-11	TCGA-W5-AA2O-01A	TCGA-W5-AA2O	180a2b9c-9cac-4d96-86e8-cd6b3b9386b5	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	2771	210.0	False	true	EDB0DC9B-6D0C-4591-81CA-BECD1BC27983	1.91	0e8deabe-78a0-4960-8dc0-1afb483f409d	0.18	23	released	4a66702a-5df8-4e37-9e6a-ffab6231c3e3	RNA	R	0.18	UV Spec	released	False	db3db200-6ce9-47a3-ab70-ac9d43d90edc	11	2.0	1.0	0.0	3.0	0.0	15.0	85.0	85.0	TOP	90e7868e-0605-43fd-a4a5-a2c0a6ac3aee	released	released	30.0	ef4d9f23-59d6-4e1f-bd19-5832aae880ab	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2O_demographic	57	-21118	640	ca7546e0-cc75-5f29-a552-c7cd36233a31	not hispanic or latino	male	white	released	Dead	1949	2007	TCGA-W5-AA2O_exposure	Not Reported	26.175194521137367	fbf24c1a-1cd5-5a58-9c9d-62afc5435fb2	167.0	released	73.0	TCGA-W5-AA2O_diagnosis	21118	M0	N0	Stage I	T1	6th	not reported	0		4c3932d9-6d7c-5bb3-8154-3b1ac6af61fa	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2006	TCGA-W5-AA2O_treatment_1	TCGA-W5-AA2O_treatment	released	687b783a-270c-54c4-a9b1-229c00db6495	no	Pharmaceutical Therapy, NOS	released	bd9e3ae1-3750-5a97-90dd-d5ea9840ec19	no	Radiation Therapy, NOS	bd31db54-5544-41e6-abab-86f2e997cfe5
8a913a99-5b8d-4ebf-9d66-b93f5c92431e.htseq.counts.gz	9796011a-fbab-409a-a850-bd890098c576	TCGA-W5-AA31-11A-11R-A41I-07	TCGA-W5-AA31-11A-11R	TCGA-W5-AA31-11A-01-TS1	TCGA-W5-AA31-11A-11	TCGA-W5-AA31-11A	TCGA-W5-AA31	2d6e20b2-82c7-4c12-92d0-93282b0a9031	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	1079	150.0	False	true		1.82	699c7545-9b63-4b7d-9f65-fc538ac31ff3	0.16	23	released	cc9ed042-3294-4043-b8f8-99ce59da97a7	RNA	R	0.16	UV Spec	released	False	3b918373-c385-4f52-b95a-a7f9bd6db020	11	2.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	ddd15a26-27ae-4c72-ab59-5f8dfd3346b2	released	released	30.0	42aea8f3-1d59-4567-bc60-54fc1e255484	Solid Tissue Normal	11	released	Not Reported	released	TCGA-W5-AA31_demographic	71	-26139		60a87b01-2cf2-5cf6-a7ef-60a01a2c39cb	not hispanic or latino	male	white	released	Alive	1939		TCGA-W5-AA31_exposure	Not Reported	31.01370510396975	f97fbe9c-eba1-55e2-b444-fc4258e0885e	184.0	released	105.0	TCGA-W5-AA31_diagnosis	26139	M0	N0	Stage I	T1	7th	not reported	0	10	31529032-9657-5095-bc21-31b5c42020df	C22.1	not reported	8160/3	Cholangiocarcinoma	yes	No	not reported	Intrahepatic bile duct	released	Not Reported	Intrahepatic bile duct	not reported	stage i	2010	TCGA-W5-AA31_treatment	TCGA-W5-AA31_treatment_1	released	5dd979a9-f240-5875-94c6-87971863b9a5	no	Radiation Therapy, NOS	released	daf3ed7d-27b9-5da4-a860-b0b484c9d5e7	no	Pharmaceutical Therapy, NOS	9796011a-fbab-409a-a850-bd890098c576
0f0e9856-1a21-4129-a791-deb93f75fa56.htseq.counts.gz	8499d831-d9d9-4279-8fbe-84d48a562ed0	TCGA-ZU-A8S4-01A-11R-A41I-07	TCGA-ZU-A8S4-01A-11R	TCGA-ZU-A8S4-01A-01-TS1	TCGA-ZU-A8S4-01A-11	TCGA-ZU-A8S4-01A	TCGA-ZU-A8S4	e76cf9a0-061e-4a7d-ba28-5a40b8da54b8	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	356	70.0	False	false	92337E74-DF14-48C7-90AC-907A787E1D0E	1.86	5cd9444b-4c4c-489a-b491-583da5510c80	0.16	23	released	0ebaae06-0b80-42e5-8bde-b7af1efd1334	RNA	R	0.16	UV Spec	released	False	35dedd56-1c03-468e-a2a2-6f51abc351f1	11	80.0	20.0	0.0	0.0	0.0	50.0	50.0	60.0	TOP	741b0e52-9b2f-477e-aba6-763b452d8985	released	released	30.0	d6684baf-8c43-46b8-8305-259fa44a9d46	Primary Tumor	01	released	Not Reported	released	TCGA-ZU-A8S4_demographic	52	-19264	98	4926c575-3e72-5ea1-89ec-1af7e2b890ad	not hispanic or latino	male	white	released	Dead	1960	2012	TCGA-ZU-A8S4_exposure	Not Reported	36.42987249544627	f951fcd6-4f47-5212-94ba-926143598ad1	183.0	released	122.0	TCGA-ZU-A8S4_diagnosis	19264	MX	NX	Stage I	T1	7th	not reported	0		40020d0b-b6bb-552f-99e8-85eadef3f5f0	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2012	TCGA-ZU-A8S4_treatment_1	TCGA-ZU-A8S4_treatment	released	42a966a8-399b-5003-b36a-7776530acf20	yes	Pharmaceutical Therapy, NOS	released	0405431f-fac3-50cb-8307-a3c7dbef8be8	no	Radiation Therapy, NOS	8499d831-d9d9-4279-8fbe-84d48a562ed0
b408c617-5d6e-4328-a973-345f41db6370.htseq.counts.gz	f38840ce-3838-40df-b5f2-ecd58bfe7c57	TCGA-W5-AA2I-01A-32R-A41I-07	TCGA-W5-AA2I-01A-32R	TCGA-W5-AA2I-01A-03-TSC	TCGA-W5-AA2I-01A-32	TCGA-W5-AA2I-01A	TCGA-W5-AA2I	3c8ca064-a4a7-416f-a069-4324d4a72038	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	3131	280.0	False	true	7C977B78-0280-4078-BA64-4D8D9554B38F	1.94	51dfbd25-fa30-4ac5-b375-fde6ddbaa151	0.17	23	released	9fc33735-a6d5-42bd-b132-96587ba1103a	RNA	R	0.17	UV Spec	released	False	582a32ba-62f9-44f1-8fc0-44afd6755b76	32	3.0	1.0	0.0	3.0	0.0	25.0	75.0	75.0	TOP	5bd2e12b-5f9f-4b24-b516-a026baa06c71	released	released	30.0	f6667bb9-cbf0-4c24-b032-5dcf966f7c37	Primary Tumor	01	released	Not Reported	released	TCGA-W5-AA2I_demographic	66	-24388	1939	2c7d4763-c4ac-514b-b61c-e8d1c7c2defa	not hispanic or latino	male	white	released	Dead	1939	2010	TCGA-W5-AA2I_exposure	Not Reported	39.4520893826537	3f1fb58b-f8bb-5aac-8f51-e8e72ded3696	178.0	released	125.0	TCGA-W5-AA2I_diagnosis	24388	M0	N0	Stage I	T1	6th	not reported	0		b196499e-cc2c-5e46-a50a-bd2ec45ecb20	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2005	TCGA-W5-AA2I_treatment_1	TCGA-W5-AA2I_treatment	released	119b1c52-dbc9-52b1-a34e-38360d6cbf9d	no	Pharmaceutical Therapy, NOS	released	10202bfb-52b1-5598-aefb-d6271b3caf3e	no	Radiation Therapy, NOS	f38840ce-3838-40df-b5f2-ecd58bfe7c57
c1071bcd-5a0c-4e09-a578-fc4b6dbe26ad.htseq.counts.gz	10d08172-48d2-49e7-b760-721163492cc1	TCGA-ZU-A8S4-11A-11R-A41I-07	TCGA-ZU-A8S4-11A-11R	TCGA-ZU-A8S4-11A-01-TS1	TCGA-ZU-A8S4-11A-11	TCGA-ZU-A8S4-11A	TCGA-ZU-A8S4	e76cf9a0-061e-4a7d-ba28-5a40b8da54b8	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	356	250.0	False	false		1.87	bd5dc5da-bd55-45d8-a045-93d99b737f0a	0.17	23	released	b4ff9bde-8339-4053-9d85-1b0f4f69d7ab	RNA	R	0.17	UV Spec	released	False	b95682c4-307b-4596-8d65-13b9f5daa80b	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	d600b84a-256e-49b6-b88b-a17cb1f20cad	released	released	30.0	e6cf7f37-b510-4bf7-aa8d-bcc400e799a3	Solid Tissue Normal	11	released	Not Reported	released	TCGA-ZU-A8S4_demographic	52	-19264	98	4926c575-3e72-5ea1-89ec-1af7e2b890ad	not hispanic or latino	male	white	released	Dead	1960	2012	TCGA-ZU-A8S4_exposure	Not Reported	36.42987249544627	f951fcd6-4f47-5212-94ba-926143598ad1	183.0	released	122.0	TCGA-ZU-A8S4_diagnosis	19264	MX	NX	Stage I	T1	7th	not reported	0		40020d0b-b6bb-552f-99e8-85eadef3f5f0	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2012	TCGA-ZU-A8S4_treatment_1	TCGA-ZU-A8S4_treatment	released	42a966a8-399b-5003-b36a-7776530acf20	yes	Pharmaceutical Therapy, NOS	released	0405431f-fac3-50cb-8307-a3c7dbef8be8	no	Radiation Therapy, NOS	10d08172-48d2-49e7-b760-721163492cc1
b6a2c03a-c8ad-41e9-8a19-8f5ac53cae9f.htseq.counts.gz	42b8d463-6209-4ea0-bb01-8023a1302fa0	TCGA-3X-AAVA-01A-11R-A41I-07	TCGA-3X-AAVA-01A-11R	TCGA-3X-AAVA-01A-01-TSA	TCGA-3X-AAVA-01A-11	TCGA-3X-AAVA-01A	TCGA-3X-AAVA	fe57b639-db7a-460f-adfe-552f1e034e46	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	510	480.0	False	true	4C9A220D-03E9-41CF-8FA9-4B7FD05A625A	1.83	6a8ffc5d-444e-4864-bafd-ddf1ef900ef0	0.17	23	released	165b1fbb-2cf4-40b8-b75c-a3d042acfd30	RNA	R	0.17	UV Spec	released	False	8ba952e5-b920-453e-ad04-17b1653e4f9a	11	0.0	0.0	0.0	0.0	10.0	40.0	50.0	60.0	TOP	11217dc9-a3a3-4676-905a-3287954ca3be	released	released	30.0	10ad01b6-09b1-4806-ad6b-6c015b26fa75	Primary Tumor	01	released	Not Reported	released	TCGA-3X-AAVA_demographic	50	-18303	445	6b62981b-e6be-50fb-9e55-19e11233b954	not hispanic or latino	female	white	released	Dead	1962	2013	TCGA-3X-AAVA_exposure	Not Reported		3af13a8b-16d9-5955-9d14-fed6a0700362		released	92.0	TCGA-3X-AAVA_diagnosis	18303	M0	NX	Stage II	T2b	7th	not reported	0		c30b61ed-f69b-54bb-b65c-a9cfa1d11346	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage ii	2012	TCGA-3X-AAVA_treatment	TCGA-3X-AAVA_treatment_1	released	6d0871d5-a804-5c01-be09-73cf2a078cc3	yes	Radiation Therapy, NOS	released	87cdd7b0-09fb-5290-a87a-7a299bbe34ad	no	Pharmaceutical Therapy, NOS	42b8d463-6209-4ea0-bb01-8023a1302fa0
4082f7d5-5656-476a-9aaf-36f7cea0ac55.htseq.counts.gz	1ace0df3-9837-467e-85de-c938efda8fc8	TCGA-3X-AAVE-01A-11R-A41I-07	TCGA-3X-AAVE-01A-11R	TCGA-3X-AAVE-01A-01-TS1	TCGA-3X-AAVE-01A-11	TCGA-3X-AAVE-01A	TCGA-3X-AAVE	dcc87c59-fd8c-4511-9983-96d5b9784cb0	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	28	60.0	False	true	15BF3FFE-B723-403A-AD20-CBB1D0C9E394	1.88	c49a7f2a-f7ef-419d-829a-0b3a9f915aad	0.16	23	released	2dcb1049-9147-45d6-b671-8307fbb546ec	RNA	R	0.16	UV Spec	released	False	42226b6c-8bab-40f4-950a-4a5a726cf1c2	11	3.0	1.0	0.0	4.0	0.0	25.0	75.0	75.0	TOP	0aa02c15-a873-446f-b290-5952e2c1d1be	released	released	30.0	671231f4-907d-44aa-af24-b8e5e440ba26	Primary Tumor	01	released	Not Reported	released	TCGA-3X-AAVE_demographic	60	-21943		70c84d96-45d5-5409-84ed-025f09ea854c	not hispanic or latino	male	asian	released	Alive	1953		TCGA-3X-AAVE_exposure	Not Reported	23.046875	9a31d447-a700-5e86-8dc8-03f8082462f3	160.0	released	59.0	TCGA-3X-AAVE_diagnosis	21943	M0	N0	Stage II	T2	7th	not reported	0	650	7e847ca8-b168-5c62-a0c8-d4398ccdbf2d	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage ii	2013	TCGA-3X-AAVE_treatment	TCGA-3X-AAVE_treatment_1	released	a172ad8f-8db9-51df-9816-0c89f19c332c	no	Radiation Therapy, NOS	released	fcd943ff-88cc-54dc-9113-7fa4f6eb60cf	no	Pharmaceutical Therapy, NOS	1ace0df3-9837-467e-85de-c938efda8fc8
38c31608-d1ad-4eb2-96f9-924f6a8d3219.htseq.counts.gz	7cde9495-e573-4b38-b89c-991076cf8cf8	TCGA-ZH-A8Y5-01A-11R-A41I-07	TCGA-ZH-A8Y5-01A-11R	TCGA-ZH-A8Y5-01A-01-TS1	TCGA-ZH-A8Y5-01A-11	TCGA-ZH-A8Y5-01A	TCGA-ZH-A8Y5	9d9109f5-5917-4126-8e34-8a7e4632e913	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	622	240.0	False	false	793D6E81-1D43-4C8F-9490-F55217AF4E8E	1.85	f7f581cf-3c93-4eaf-9f10-299006f058ce	0.17	23	released	21c9c876-6e9f-488a-8eb4-17f3d823bb1d	RNA	R	0.17	UV Spec	released	False	3945ce41-d0ed-4b25-9462-128de183a315	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	TOP	7d6c4039-cda3-4cb3-b040-d4dbb1fa9105	released	released	30.0	c333b64d-64b7-448f-a786-ee7b82b84b06	Primary Tumor	01	released	Not Reported	released	TCGA-ZH-A8Y5_demographic	69	-25268		c47cf15a-3740-57dd-a3ec-1ab5432a11ee	not hispanic or latino	male	white	released	Alive	1943		TCGA-ZH-A8Y5_exposure	Not Reported	27.755102040816325	808627cb-d7cc-51b3-acda-a877862e106e	175.0	released	85.0	TCGA-ZH-A8Y5_diagnosis	25268	M1	N1	Stage IVB	T3	7th	not reported	0	1229	eaa088ed-13bc-5c86-a7f0-9ce4c0c9aa1d	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage ivb	2012	TCGA-ZH-A8Y5_treatment_1	TCGA-ZH-A8Y5_treatment	released	5b2ae7c5-6156-56b4-b400-7fdf09540e42	yes	Pharmaceutical Therapy, NOS	released	00693524-5770-50e9-8f57-c4336686fdef	no	Radiation Therapy, NOS	7cde9495-e573-4b38-b89c-991076cf8cf8
fbdb830c-2f70-45f5-a2d6-2d8317301af3.htseq.counts.gz	d9249d25-d852-4008-a71e-dd9be6cb68e9	TCGA-W5-AA34-11A-11R-A41I-07	TCGA-W5-AA34-11A-11R	TCGA-W5-AA34-11A-01-TSA	TCGA-W5-AA34-11A-11	TCGA-W5-AA34-11A	TCGA-W5-AA34	adc9a685-5b4a-4c29-881a-da1895c47520	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	461	250.0	False	true		1.8	9d7ac93a-ca45-44ed-a326-5e404e0d3b85	0.17	23	released	ebad7df9-9c82-419d-b0e1-886c6a827d0e	RNA	R	0.17	UV Spec	released	False	d4a26211-b957-4ba4-b4bb-8bbb3b42bdd1	11	2.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	273f93c0-d071-48f0-8ef8-94c86ec75a68	released	released	30.0	21de0435-9ebb-4d1f-8579-917469dac41c	Solid Tissue Normal	11	released	Not Reported	released	TCGA-W5-AA34_demographic	75	-27535	555	42a98d55-df9c-511a-9467-5da4039dda49	not hispanic or latino	female	white	released	Dead	1937		TCGA-W5-AA34_exposure	Not Reported	27.734375	1aec3b10-8e5e-5a7d-8c4a-0aefea9690ed	160.0	released	71.0	TCGA-W5-AA34_diagnosis	27535	M0	N0	Stage I	T1	7th	not reported	0	168	d5ff64fb-4fe3-5ae2-b674-3e3176c2c30f	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2012	TCGA-W5-AA34_treatment	TCGA-W5-AA34_treatment_1	released	a170e48a-8238-503b-b904-c9a3e42b9d02	no	Radiation Therapy, NOS	released	aca43ad4-50da-55d1-a62d-bb34a761b7b9	yes	Pharmaceutical Therapy, NOS	d9249d25-d852-4008-a71e-dd9be6cb68e9
a4db2c6c-403b-4ea1-9b54-d2aae853389c.htseq.counts.gz	b886634e-e0a7-459a-a2c9-20fabb779dc6	TCGA-ZD-A8I3-01A-11R-A41I-07	TCGA-ZD-A8I3-01A-11R	TCGA-ZD-A8I3-01A-01-TSA	TCGA-ZD-A8I3-01A-11	TCGA-ZD-A8I3-01A	TCGA-ZD-A8I3	ccb028ae-777c-4af6-b92e-40848f1cf774	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	173	250.0	False	true	0A18D59B-0D93-409E-8E7F-156B1C77964B	1.81	be89bf4d-75f7-4596-9251-490976f7e254	0.17	23	released	f8fe9254-d566-43dd-8f9f-ed603be147ff	RNA	R	0.17	UV Spec	released	False	8a97551b-320e-4274-ab63-9bd2043926e1	11	15.0	2.0	5.0	2.0	0.0	72.0	23.0	75.0	TOP	0925713d-ce8d-4090-8886-dd6c2693e020	released	released	30.0	d711760d-902d-45c1-83c6-b6671a8627aa	Primary Tumor	01	released	Not Reported	released	TCGA-ZD-A8I3_demographic	73	-26754	169	1959d96d-7924-5bd7-aaf6-8a2525d1b889	not hispanic or latino	female	asian	released	Dead	1940		TCGA-ZD-A8I3_exposure	Not Reported	21.208448753462605	abae74e1-9815-5169-a91f-a1b415e21400	152.0	released	49.0	TCGA-ZD-A8I3_diagnosis	26754	M0	N0	Stage II	T2	7th	not reported	0	0	1f2db330-e21e-50ed-a178-1d332dbfb516	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage ii	2013	TCGA-ZD-A8I3_treatment_1	TCGA-ZD-A8I3_treatment	released	12bbed9c-df3f-5c96-b4c9-fab17f4b4c7c	no	Pharmaceutical Therapy, NOS	released	6518c117-5a77-5592-8b40-966bcf21b8f3	no	Radiation Therapy, NOS	b886634e-e0a7-459a-a2c9-20fabb779dc6
8f00d52e-9dde-4594-87a1-8946bc7fb438.htseq.counts.gz	b74b20b7-2797-4266-8f56-166978275576	TCGA-4G-AAZO-01A-12R-A41I-07	TCGA-4G-AAZO-01A-12R	TCGA-4G-AAZO-01A-01-TS1	TCGA-4G-AAZO-01A-12	TCGA-4G-AAZO-01A	TCGA-4G-AAZO	0775583e-c0a0-4f18-9ca2-8f89cedce3d6	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	630	90.0	False	false	C6A65949-C248-4729-B41F-9C65A46A7AF7	1.84	f36ef26a-5c56-422b-bcdf-4693615d026b	0.18	23	released	4eea2e2e-02d5-4b98-87d1-3fab9328432a	RNA	R	0.18	UV Spec	released	False	35c2502b-7821-493e-a53e-994d6eabf71e	12	4.0	0.0	15.0	0.0	0.0	40.0	45.0	90.0	TOP	6b4f7d2a-3ad9-4ba0-92ae-020618504740	released	released	30.0	e570797a-11f8-4630-9b2f-806f5b61c0f5	Primary Tumor	01	released	Not Reported	released	TCGA-4G-AAZO_demographic	71	-25989		5d6ef589-fa83-5b26-981e-7d11a4577bad	not hispanic or latino	female	white	released	Alive	1941		TCGA-4G-AAZO_exposure	Not Reported	25.847768218818715	91a7368d-c880-5de8-a0cc-5172b80b4d90	161.0	released	67.0	TCGA-4G-AAZO_diagnosis	25989	M0	N0	Stage II	T2a	7th	not reported	0	1177	2bcadf8d-e058-5422-a2e8-d084875af845	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage ii	2012	TCGA-4G-AAZO_treatment_1	TCGA-4G-AAZO_treatment	released	6f591e33-93db-5dea-8474-413a245b6a2e	yes	Pharmaceutical Therapy, NOS	released	cbc27a01-1586-57ce-9b35-2e3208abff31	no	Radiation Therapy, NOS	b74b20b7-2797-4266-8f56-166978275576
4696ce44-29bf-41ea-b866-ddb17c376e94.htseq.counts.gz	be2d52c8-eb14-4b45-a65b-c1bdd6f5c4c2	TCGA-ZH-A8Y6-01A-11R-A41I-07	TCGA-ZH-A8Y6-01A-11R	TCGA-ZH-A8Y6-01A-01-TS1	TCGA-ZH-A8Y6-01A-11	TCGA-ZH-A8Y6-01A	TCGA-ZH-A8Y6	5166d82f-7b22-4101-bea9-6056e5a74c48	Adenomas and Adenocarcinomas	Liver and intrahepatic bile ducts	TCGA-CHOL	148	350.0	False	false	1308ED5B-3B3F-4E9A-91D6-64507F549473	1.86	f322aedd-a561-4b14-b2e3-f60087b705f7	0.17	23	released	1964d671-8d70-4e7a-9945-bc4424f74f28	RNA	R	0.17	UV Spec	released	False	92dbd39a-8356-4b3b-909d-7b84520487eb	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	2e276578-18e5-41af-86e8-55761dd0aef9	released	released	30.0	c7440d32-f1f1-41d6-9863-ba25cc622495	Primary Tumor	01	released	Not Reported	released	TCGA-ZH-A8Y6_demographic	41	-14976		5759a210-cb0a-58e8-9f9b-eb02ebd888d2	not hispanic or latino	female	black or african american	released	Alive	1972		TCGA-ZH-A8Y6_exposure	Not Reported	38.52146814404432	778be807-4a92-5e5d-b159-4ee39cf748dd	152.0	released	89.0	TCGA-ZH-A8Y6_diagnosis	14976	M0	N0	Stage I	T1	7th	not reported	0	519	6c85eb4d-2d0d-5095-9e9b-43e5a6eaf133	C22.1	not reported	8160/3	Cholangiocarcinoma	no	No	not reported	Intrahepatic bile duct	released	No	Intrahepatic bile duct	not reported	stage i	2013	TCGA-ZH-A8Y6_treatment	TCGA-ZH-A8Y6_treatment_1	released	1ca3f523-c328-585d-8e7a-8b18b8243807	no	Radiation Therapy, NOS	released	ee6cf626-7c4b-501a-816f-3091efb3d356	no	Pharmaceutical Therapy, NOS	be2d52c8-eb14-4b45-a65b-c1bdd6f5c4c2